FRIP, a hematopoietic cell-specific rasGAP-interacting protein phosphorylated in response to cytokine stimulation

Immunity

Volumn 9, Issue 1, 1998, Pages 13-24

  Nelms, Keats ^a   Snow, Andrew L ^a   Hu Li, Jane ^a   Paul, William E ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR;

ARTICLE; CELL SPECIFICITY; GENE LOCUS; GENE MAPPING; HEMATOPOIESIS; HEMATOPOIETIC CELL; HUMAN; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 0032126362     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80584-1     Document Type: Article

References (64)

1. raf-1. EMBO J. 13, 1610-1619.
2. Angel, P., and Karin, M. (1991). The role of Jun, Fos, and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta 1072, 129-157.
3. Boguski, M.S., and McCormick, F. (1993). Proteins regulating Ras and its relatives. Nature 366, 643-654.
4. Burns, L.A., Karnitz, L.M., Sutor, S.L., and Abraham, R.T. (1993). Interleukin-2-induced tyrosine phosphorylation of p52shc in T lymphocytes. J. Biol. Chem. 268, 17659-17661.
5. Canchon-Gonzalez, M.B. (1994). Structure and expression of the hairless gene of mice. Proc. Natl. Acad. Sci. USA 91, 7717-7721.
6. Carpino, N., Wisniewski, D., Strife, A., Marshak, D., Kobayashi, R., Stillman, B., and Clarkson, B. (1997). p62(dok): a constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells. Cell 88, 197-204.
7. Coffman, R.L., Lebman, D.A., and Rothman, P. (1993). Mechanism and regulation of immunoglobulin isotype switching. Adv. Immunol. 54, 229-270.
8. Conrad, D., Waldschmidt, T.J., Lee, W.T., Rao, M., Keegan, A.D., Noelle, R.J., Lynch, R.G., and Kehry, M.R. (1987). Effect of B cell stimulatory factor-1 (interleukin-4) on Fc epsilon and Fc gamma receptor expression on murine B lymphocytes and B cell lines. J. Immunol. 139, 2290-2296.
9. Crowley, M.T., Harmer, S.L., and DeFranco, A.L. (1996). Activation-induced association of a 145-kDa tyrosine-phosphorylated protein with Shc and Syk in B lymphocytes and macrophages. J. Biol. Chem. 271, 1145-1152.
10. Cutler, R.L., Liu, L., Damen, J.E., and Krystal, G. (1993). Multiple cytokines induce the tyrosine phosphorylation of Shc and its association with Grb2 in hemopoietic cells. J. Biol. Chem. 268, 21463-21465.
11. dok-2 defines a new family of RasGAP-binding proteins. J. Biol. Chem. 273, 4827-4830.
12. Downward, J. (1996). Control of ras activation. Cancer Surv. 27, 87-100.
13. Eck, M.J., Dhe-Paganon, S., Trub, T., Nolte, R.T., and Shoelson, S.E. (1996). Structure of the IRS-1 PTB domain bound to the juxtamembrane region of the insulin receptor. Cell 85, 695-705.
14. Evans, G.A., Goldsmith, M.A., Johnston, J.A., Xu, W., Weiler, S.R., Erwin, R., Howard, O.M., Abraham, R.T., O'Shea, J.J., Greene, W.C., et al. (1995). Analysis of interleukin-2-dependent signal transduction through the Shc/Grb2 adapter pathway. Interleukin-2-dependent mitogenesis does not require Shc phosphorylation or receptor association. J. Biol. Chem. 270, 28858-28863.
15. Golemis, E.A., and Brent, R. (1992). Fused protein domains inhibit DNA binding by LexA. Mol. Cell Biol. 12, 3006-3014.
16. Gyuris, J., Golemis, E., Chertkov, H., and Brent, R. (1993). Cdi1, a human G1 and S phase protein phosphatase that associates with Cdk2. Cell 75, 791-803.
17. Heiniger, H.J., Meier, H., Kaliss, N., Cherry, M., Chen, H.W., and Stoner, R.D. (1974). Hereditary immunodeficiency and leukemogenesis in HRS-J mice. Cancer Res. 34, 201-211.
18. Hou, J., Schindler, U., Henzel, W.J., Ho, T.C., Brasseur, M., and McKnight, S.L. (1994). An interleukin-4 induced transcription factor: IL-4 Stat. Science 265, 1701-1706.
19. Hu-Li, J., Ohara, J., Watson, C., Tsang, W., and Paul, W.E. (1989). Derivation of a T cell line that is highly responsive to IL-4 and IL-2 (CT.4R) and of an IL-2 hyporesponsive mutant of that line (CT.4S). J. Immunol. 142, 800-807.
20. Hu-Li, J., Huang, H., Ryan, J., and Paul, W.E. (1997). In differentiated CD4+ T cells, interleukin 4 production is cytokine-autonomous, whereas Interferon gamma production iscytokine-dependent. Proc. Natl Acad. Sci. USA 94, 3189-3194.
21. Huang, H., Hu-Li, J., Chen, H., Ben-Sasson, S.Z., and Paul, W.E. (1997). IL-4 and IL-13 production in differentiated TH2 cells is not IL-4 dependent. J. Immunol. 159, 3731-3738.
22. Keegan, A.D., Nelms, K., White, M., Wang, L.M., Pierce, J.H., and Paul, W.E. (1994). An IL-4 receptor region containing an insulin receptor motif is important for IL-4-mediated IRS-1 phosphorylation and cell growth. Cell 76, 811-820.
23. Lee, F., Yokota, T., Otsuka, T., Meyerson, P., Villaret, D., Coffman, R., Mosmann, T., Rennick, D., Roeham, N., Smith, C., et al. (1986). Isolation and characterization of a mouse interleukin-4 cDNA clone that expresses B-cell stimulatory factor 1 activities and T-cell and mast-cell stimulating activities. Proc. Natl Acad. Sci. USA 83, 2061-2065.
24. Lemmon, M.A., Ferguson, K.M., O'Brien, R., Sigler, P.B., and Schlessinger, J. (1995). Specific and high-affinity binding of inositol phosphates to an isolated pleckstrin homology domain. Proc. Natl Acad. Sci. USA 92, 10472-10476.
25. Leonard, W.J., Shores, E.W., and Love, P.E. (1995). Role of the common cytokine receptor gamma chain in cytokine signaling and lymphoid development. Immunol. Rev. 48, 97-114.
26. Marengere, L.E., and Pawson, T. (1992). Identification of residues in GTPase-activating protein Src homology 2 domains that control binding to tyrosine phosphorylated growth factor receptors and p62. J. Biol. Chem. 267, 22779-22786.
27. Margolis, B., and Skolnik, E.Y. (1994). Activation of Ras by receptor tyrosine kinases. J. Am. Soc. Nephrol. 5, 1288-1299.
28. Matsuguchi, T., Salgia, R., Hallek, M., Eder, M., Druker, B., Ernst, T.J., and Griffin, J.D. (1994). Shc phosphorylation in myeloid cells is regulated by granulocyte macrophage colony-stimulating factor, interleukin-3, and steel factor and is constitutively increased by p210BCR/ABL J. Biol. Chem. 269, 5016-5021.
29. Meier, H., Myers, D.D., and Huebner, R.J. (1963). Genetic control by the hr-locus of susceptibility and resistance to leukemia. Proc. Natl. Acad. Sci. USA 63, 759-766.
30. Morrissey, P.J., Parkinson, D.R., Schwartz, R.S., and Waksal, S.D. (1980). Immunologic abnormalities in HRS/J mice: specific deficit in T lymphocyte helper function in a mutant mouse. J. Immunol. 125, 1558-1562.
31. Myers, M.G., Jr., Sun, X.J., and White, M.F. (1994). The IRS-1 signaling system. Trends Biochem. Sci. 19, 289-293.
32. Noelle, R., Krammer, P.M., Ohara, J., Uhr, J.W., and Vitetta, E.S. (1984). Increased expression of Ia antigens on resting B cells: an additional role for B-cell growth factor. Proc. Natl. Acad. Sci. USA 81, 6149-6153.
33. O'Neill, T.J., Craparo, A., and Gustafson, T.A. (1994). Characterization of an interaction between insulin receptor substrate 1 and the insulin receptor by using the two-hybrid system. Mol. Cell Biol. 14, 6433-6442.
34. Ota, Y., and Samelson, L.E. (1997). The product of the proto-oncogene c-cbl: a negative regulator of the Syk tyrosine kinase. Science 276, 418-420.
35. Pawson, T. (1995). Protein modules and signaling networks. Nature 373, 573-580.
36. Pelicci, G., Lanfrancone, L., Grignani, F., McGlade, J., Cavallo, F., Forni, G., Nicoletti, I., Grignani, F., Pawson, T., and Pelicci, P.G. (1992). A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell 70, 93-104.
37. Perkins, G.R., Marvel, J., and Collins, M.K. (1993). Interleukin 2 activates the extracellular signal-regulated protein kinase 2. J. Exp. Med. 178, 1429-1434.
38. Ravichandran, K.S., and Burakoff, S.J. (1994). The adapter protein Shc interacts with the interleukin-2 (IL-2) receptor upon IL-2 stimulation. J. Biol. Chem. 269, 1599-1602.
39. Ren, R., Mayer, B.J., Cicchetti, P., and Baltimore, D. (1993). Identification of a ten-amino acid proline-rich SH3 binding site. Science 259, 1157-1161.
40. Reske-Kunz, A.B., Scheid, M.P., and Boyse, E.A. (1979). Disproportion in T-cell subpopulations in immunodeficient mutant hr/hr mice. J. Exp. Med. 149, 228-233.
41. Rozakis-Adcock, M., McGlade, J., Mbamalu, G., Pelicci, G., Daly, R., Li, W., Batzer, A., Thomas, S., Brugge, J., Pelicci, P.G., et al. (1992). Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. Nature 360, 689-692.
42. Ryan, J.J., McReynolds, L.J., Keegan, A., Wang, L.H., Garfein, E., Rothman, P., Nelms, K., and Paul, W.E. (1996). Growth and gene expression are predominantly controlled by distinct regions of the human IL-4 receptor. Immunity 4, 123-132.
43. Salcini, A.E., McGlade, J., Pelicci, G., Nicoletti, I., Pawson, T., and Pelicci, P.G. (1994). Formation of Shc-Grb2 complexes is necessary to induce neoplastic transformation by overexpression of Shc proteins. Oncogene 9, 2827-2836.
44. Scharenberg, A.M., and Kinet, J.P. (1996). The emerging field of receptor-mediated inhibitory signaling: SHP or SHIP? Cell 87, 961-964.
45. Seder, R.A., and Paul, W.E. (1994). Acquisition of lymphokine-producing phenotypeby CD4+ T cells. Ann. Rev. Immunol. 12, 635-673.
46. Shibuya, H., Yoneyama, M., Ninomiya-Tsuji, J., Matsumoto, K., and Taniguchi, T. (1992). IL-2 and EGF receptors stimulate the hematopoietic cell cycle via different signaling pathways: demonstration of a novel role for c-myc. Cell 70, 57-67.
47. Songyang, Z., Shoelson, S.E., Chaudhuri, M., Gish, G., Pawson, T., Haser, W.G., King, F., Roberts, T., Ratnofsky, S., Lechleider, R.J., et al. (1993). SH2 domains recognize specific phosphopeptide sequences. Cell 72, 767-778.
48. Songyang, Z., Carraway, K.L.R., Eck, M.J., Harrison, S.C., Feldman, R.A., Mohammadi, M., Schlessinger, J., Hubbard, S.R., Smith, D.P., Eng, C., et al. (1995). Catalytic specificity of protein-tyrosine kinases is critical for selective signaling. Nature 373, 536-539.
49. Stoye, J.P., Fenner, S., Greenoak, G.E., Moran, C., and Coffin, J.M. (1988). Role of endogenous retroviruses as mutagens: the hairless mutation of mice. Cell 54, 383-391.
50. Sun, X.J., Wang, L.M., Zhang, Y., Yenush, L., Myers, M.G.J., Glasheen, E., Lane, W.S., Pierce, J.H., and White, M.F. (1995). Role of IRS-2 in insulin and cytokine signaling. Nature 377, 173-177.
51. Trub, T., Choi, W.E., Wolf, G., Ottinger, E., Chen, Y., Weiss, M., and Shoelson, S.E. (1995). Specificity of the PTB domain of Shc for beta turn-forming pentapeptide motifs amino-terminal to phosphotyrosine. J. Biol. Chem. 270, 18205-18208.
52. Wang, L.M., Keegan, A.D., Li, W., Lienhard, G.E., Pacini, S., Gutkind, J.S., Myers, M.G., Jr., Sun, X.J., White, M., Aaronson, S.A., et al. (1993a). Common elements in interleukin-4 and insulin signaling pathways in factor-dependent hematopoietic cells. Proc. Natl. Acad. Scei. USA 90, 4032-4036.
53. Wang, L.M., Myers, M.G., Jr., Sun, X.J., Aaronson, S.A., White, M., and Pierce, J.H. (1993b). IRS-1: essential for insulin-and IL-4-stimulated mitogenesis in hematopoietic cells. Science 261, 1591-1594.
54. Wang, H.Y., Paul, W.E., and Keegan, A.D. (1996). IL-4 function can be transferred to the IL-2 receptor by tyrosine containing sequences found in the IL-4 receptor alpha chain. Immunity 4, 113-121.
55. Welham, M.J., Duronio, V., Leslie, K.B., Bowtell, D., and Schrader, J.W. (1994). Multiple hemopoietins, with the exception of interleukin-4, induce modification of Shc and mSos1, but not their translocation. J. Biol. Chem. 269, 21165-21176.
56. White, M.F., and Kahn, C.R. (1994). The insulin signaling system. J. Biol. Chem. 269, 1-4.
57. Wolf, G., Trub, T., Ottinger, E., Groninga, L., Lynch, A., White, M., Miyazaki, M., Lee, J., and Shoelson, S.E. (1995). The PTB domains of IRS-1 and Shc have distinct but overlapping binding specificities. J. Biol. Chem. 270, 27407-27410.
58. Yagisawa, H., Hirata, M., Kanematsu, T., Watanabe, Y., Ozaki, S., Sakuma, K., Tanaka, H., Yabuta, N., Kamata, H., Hirata, H., et al. (1994). Expression and characterization of aninositol 1,4,5-trisphosphate binding domain of phosphatidylinositol-specific phospholipase C-delta 1. J. Biol. Chem. 269, 20179-20188.
59. Yamanashi, Y., and Baltimore, D. (1997). Identification of the AbI-and rasGAP-associated 62 kDa protein as a docking protein, Dok. Cell 88, 205-211.
60. Yu, H., Chen, J.K., Feng, S., Dalgarno, D.C., Brauer, A.W., and Schreiber, S.L. (1994). Structural basis for the binding of prolinerich peptides to SH3 domains. Cell 76, 933-945.
61. Zamorano, J., Wang, H.Y., Wang, L.M., Pierce, J.H., and Keegan, A.D. (1996). IL-4 protects cells from apoptosis viathe insulin receptor substrate pathway and a second independent signaling pathway. J. Immunol. 157, 4926-4934.
62. Zervos, A.S., Gyuris, J., and Brent, R. (1993). Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell 72, 223-232.
63. Zheng, C.F., and Guan, K.L. (1994). Activation of MEK family kinases requires phosphorylation of two conserved Ser/Thr residues. EMBO J. 13, 1123-1131.
64. Zhou, M.M., Huang, B., Olejniczak, E.T., Meadows, R.P., Shuker, S.B., Miyazaki, M., Trub, T., Shoelson, S.E., and Fesik, S.W. (1996). Structural basis for IL-4 receptor phosphopeptide recognition by the IRS-1 PTB domain. Nat. Struct. Biol. 3, 388-393.